A randomized trial of olanzapine versus palonosetron versus infused ondansetron for the treatment of breakthrough chemotherapy-induced nausea and vomiting in patients undergoing hematopoietic stem cell transplantation

被引：0
|
作者：
Midori Nakagaki
Michael Barras
Cameron Curley
Jason P. Butler
Glen A. Kennedy
机构：
[1] Royal Brisbane and Women’s Hospital,Pharmacy Department, Level 1 Ned Hanlon Building
[2] The University of Queensland,Bone Marrow Transplant Unit, Level 5 Joyce Tweddell Building
[3] Royal Brisbane and Women’s Hospital,undefined
来源：
Supportive Care in Cancer | 2017年 / 25卷
关键词：
Stem cell transplantation; Antiemetics; Ondansetron; Palonosetron; Olanzapine; Nausea and vomiting;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：607 / 613
页数：6
相关论文
共 50 条
  • [31] Effectiveness of Olanzapine Combined with Ondansetron in Prevention of Chemotherapy-Induced Nausea and Vomiting of Non-small Cell Lung Cancer
    Xin Wang
    Lei Wang
    Huayong Wang
    Hao Zhang
    Cell Biochemistry and Biophysics, 2015, 72 : 471 - 473
  • [32] Effectiveness of Olanzapine Combined with Ondansetron in Prevention of Chemotherapy-Induced Nausea and Vomiting of Non-small Cell Lung Cancer
    Wang, Xin
    Wang, Lei
    Wang, Huayong
    Zhang, Hao
    CELL BIOCHEMISTRY AND BIOPHYSICS, 2015, 72 (02) : 471 - 473
  • [33] Olanzapine treatment effectively relieves breakthrough chemotherapy-induced nausea and vomiting: a real-world experience
    Uchiike, Akihiro
    Kono, Haruka
    Miura, Katsuhiro
    Hayama, Tatsuya
    Tsutsumi, Daisuke
    Tsuboi, Shinya
    Ohtsuka, Susumu
    Hidaka, Shinji
    JOURNAL OF PHARMACEUTICAL HEALTH CARE AND SCIENCES, 2023, 9 (01)
  • [34] Olanzapine treatment effectively relieves breakthrough chemotherapy-induced nausea and vomiting: a real-world experience
    Akihiro Uchiike
    Haruka Kono
    Katsuhiro Miura
    Tatsuya Hayama
    Daisuke Tsutsumi
    Shinya Tsuboi
    Susumu Ohtsuka
    Shinji Hidaka
    Journal of Pharmaceutical Health Care and Sciences, 9
  • [35] Palonosetron is a Better Choice Compared With Ondansetron for the Prevention of Chemotherapy-induced Nausea and Vomiting (CINV) in a Resource-limited Pediatric Oncology Center: Results From a Randomized Control Trial
    Chaudhary, Narendra K.
    John, Rikki R.
    Boddu, Deepthi
    Mahasampath, Gowri
    Nesadeepam, Nalini
    Mathew, Leni G.
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2019, 41 (04) : 294 - 297
  • [36] Palonosetron and dexamethasone for the prevention of nausea and vomiting in patients receiving allogeneic hematopoietic stem cell transplantation
    Su-Peng Yeh
    Woei-Chung Lo
    Ching-Yun Hsieh
    Li-Yuan Bai
    Ching-Chan Lin
    Po-Han Lin
    Chen-Yuan Lin
    Yu-Min Liao
    Chang-Fang Chiu
    Supportive Care in Cancer, 2014, 22 : 1199 - 1206
  • [37] Palonosetron versus ondansetron for prophylaxis of postoperative nausea and vomiting in laparoscopic cholecystectomy: a non-inferiority randomized controlled trial
    Davolos, Francisco Jose Chiaradia
    Modolo, Norma S.
    Braz, Leandro G.
    do Nascimento Jr, Paulo
    BRAZILIAN JOURNAL OF ANESTHESIOLOGY, 2024, 74 (01):
  • [38] Randomized phase III trial of APF530 versus palonosetron in the prevention of chemotherapy-induced nausea and vomiting in a subset of patients with breast cancer receiving moderately or highly emetogenic chemotherapy
    Boccia, Ralph
    O'Boyle, Erin
    Cooper, William
    BMC CANCER, 2016, 16
  • [39] Randomized phase III trial of APF530 versus palonosetron in the prevention of chemotherapy-induced nausea and vomiting in a subset of patients with breast cancer receiving moderately or highly emetogenic chemotherapy
    Ralph Boccia
    Erin O’Boyle
    William Cooper
    BMC Cancer, 16
  • [40] Double-blind comparative trial of oral ondansetron versus oral granisetron versus IV ondansetron in the prevention of nausea and vomiting associated with highly emetogenic preparative regimens prior to stem cell transplantation
    Fox-Geiman, MP
    Fisher, SG
    Kiley, K
    Fletcher-Gonzalez, D
    Porter, N
    Stiff, P
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2001, 7 (11) : 596 - 603
12345